-
1دورية أكاديمية
عنوان ترانسليتريتد: Stratégies de ciblage spécifique de la tumeur fondées sur les caractéristiques des antigènes tumoraux et du microenvironnement tumoral.
المؤلفون: Mangeat T; IRCM, Institut de Recherche en Cancérologie de Montpellier U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Gracia M; IRCM, Institut de Recherche en Cancérologie de Montpellier U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Martineau P; IRCM, Institut de Recherche en Cancérologie de Montpellier U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France., Robert B; IRCM, Institut de Recherche en Cancérologie de Montpellier U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2020 Oct; Vol. 36 Hors série n° 1, pp. 56-60. Date of Electronic Publication: 2020 Oct 14.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5381 (Electronic) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal*/isolation & purification , Antibodies, Monoclonal*/therapeutic use, Antigens, Neoplasm/*isolation & purification , Molecular Targeted Therapy/*methods , Neoplasms/*immunology , Neoplasms/*therapy , Tumor Microenvironment/*immunology, Animals ; Antibody Specificity ; Antigens, Neoplasm/immunology ; Drug Delivery Systems/methods ; Epitope Mapping/methods ; Humans ; Prodrugs/therapeutic use ; Tumor Hypoxia/immunology
-
2دورية أكاديمية
عنوان ترانسليتريتد: Rôle de la voie de l'IGF dans les cancers bronchiques.
المؤلفون: Moro-Sibilot D; UF oncologie thoracique, pole de médecine aiguë communautaire, CHU Albert-Michallon, BP 217, 38043 Grenoble cedex 9, France. DMoro.pneumo@chu-grenoble.fr, Coudurier M, Lantuejoul S
المصدر: Revue des maladies respiratoires [Rev Mal Respir] 2010 Oct; Vol. 27 (8), pp. 959-63. Date of Electronic Publication: 2010 Sep 17.
نوع المنشور: English Abstract; Journal Article; Review
بيانات الدورية: Publisher: Elsevier-Masson Country of Publication: France NLM ID: 8408032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-2588 (Electronic) Linking ISSN: 07618425 NLM ISO Abbreviation: Rev Mal Respir Subsets: MEDLINE
مواضيع طبية MeSH: Immunotherapy*, Antibodies, Monoclonal/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*therapy , Insulin-Like Growth Factor I/*physiology , Lung Neoplasms/*therapy , Neoplasm Proteins/*physiology , Receptor, IGF Type 1/*physiology, Animals ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/physiopathology ; Clinical Trials as Topic ; Combined Modality Therapy ; Disease-Free Survival ; Drug Delivery Systems ; Drug Screening Assays, Antitumor ; Humans ; Insulin-Like Growth Factor Binding Protein 3 ; Insulin-Like Growth Factor Binding Proteins/physiology ; Lung Neoplasms/drug therapy ; Lung Neoplasms/physiopathology ; Neoplasm Proteins/antagonists & inhibitors ; Receptor, IGF Type 1/antagonists & inhibitors ; Receptor, IGF Type 1/immunology ; Signal Transduction
-
3دورية أكاديمية
عنوان ترانسليتريتد: Les complications << toxiques >> liées à l'utilisation des anticorps monoclonaux.
المؤلفون: Pallardy M; Université Paris-Sud, Inserm UMR-S 749, toxicologie, Faculté de pharmacie, 92290 Châtenay-Malabry, France. marc.pallardy@u-psud.fr
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1130-4.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*adverse effects, Animals ; Antibodies, Anti-Idiotypic/biosynthesis ; Antibodies, Anti-Idiotypic/immunology ; Antibodies, Monoclonal/therapeutic use ; Autoimmune Diseases/chemically induced ; Cardiomyopathies/chemically induced ; Cytokines/metabolism ; Drug Delivery Systems ; Drug Eruptions/etiology ; Drug Evaluation, Preclinical ; Gastrointestinal Diseases/chemically induced ; Humans ; Immune Complex Diseases/chemically induced ; Immunosuppression Therapy/adverse effects ; Mice ; Opportunistic Infections/etiology
-
4دورية أكاديمية
عنوان ترانسليتريتد: Anticorps thérapeutiques et dérivés : une palette de structures pour une pléthore d'indications. Quel format et quelle glycosylation choisir ? Pour quelles applications ?
المؤلفون: Beck A; Centre d'immunologie Pierre Fabre (www.cipf.com), 5, avenue Napoléon III, 74160 Saint-Julien-en-Genevois, France. alain.beck@pierre-fabre.com, Wagner-Rousset E, Wurch T, Corvaia N
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1024-32.
نوع المنشور: English Abstract; Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use, Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibody Diversity ; Drug Delivery Systems ; Glycosylation ; Humans ; Immunoconjugates/therapeutic use ; Immunoglobulin Fragments/chemistry ; Immunoglobulin Fragments/immunology ; Immunoglobulin G/chemistry ; Immunoglobulin G/immunology ; Immunoglobulin G/therapeutic use ; Mice ; Protein Conformation ; Protein Engineering ; Protein Processing, Post-Translational ; Recombinant Fusion Proteins/chemistry ; Recombinant Fusion Proteins/therapeutic use ; Species Specificity ; Structure-Activity Relationship
-
5دورية أكاديمية
عنوان ترانسليتريتد: Les anticorps : mieux les connaître pour mieux s'en servir.
المؤلفون: Abès R; Laboratoire français du fractionnement et des biotechnologies, Les Ulis, France. Inserm U872, Paris, F-75006 France., Dutertre CA, Teillaud JL
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1011-9.
نوع المنشور: English Abstract; Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antigen-Antibody Reactions/*immunology, Animals ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/immunology ; Antibody Specificity ; Antigens, Neoplasm/immunology ; Antigens, Surface/immunology ; Complementarity Determining Regions/chemistry ; Complementarity Determining Regions/immunology ; Cytokines/antagonists & inhibitors ; Cytokines/immunology ; Drug Delivery Systems ; Epitopes/immunology ; Humans ; Immunoconjugates/therapeutic use ; Immunoglobulin Fab Fragments/chemistry ; Immunoglobulin Fab Fragments/immunology ; Immunoglobulin Fc Fragments/chemistry ; Immunoglobulin Fc Fragments/immunology ; Mice ; Neoplasms/immunology ; Neoplasms/therapy ; Protein Engineering ; Risk Assessment
-
6دورية أكاديمية
عنوان ترانسليتريتد: Pharmacocinétique des anticorps monoclonaux.
المؤلفون: Paintaud G; Université François Rabelais de Tours, << Génétique, immunothérapie, chimie et cancer >>, France. paintaud@med.univ-tour.fr
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1057-62.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*pharmacokinetics, Absorption ; Animals ; Antibodies, Anti-Idiotypic/biosynthesis ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/metabolism ; Antibodies, Monoclonal/therapeutic use ; Drug Administration Routes ; Drug Delivery Systems ; Endothelial Cells/metabolism ; Female ; Histocompatibility Antigens Class I/immunology ; Humans ; Immunoglobulin Fc Fragments/immunology ; Immunoglobulin G/immunology ; Immunoglobulin G/metabolism ; Immunoglobulin G/therapeutic use ; Male ; Mice ; Pinocytosis ; Pregnancy ; Receptors, Fc/immunology ; Species Specificity ; Tissue Distribution
-
7دورية أكاديمية
عنوان ترانسليتريتد: Les immunoconjugués, anticorps << armés >> pour combattre le cancer.
المؤلفون: Haeuw JF; Centre d'immunologie Pierre Fabre, 5, avenue Napoléon III, BP 60497, 74160 Saint-Julien-en-Genevois, France. jean.francois.haeuw@ pierre-fabre.com, Caussanel V, Beck A
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1046-52.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents/*therapeutic use , Immunoconjugates/*therapeutic use , Neoplasms/*drug therapy, Aminobenzoates/administration & dosage ; Aminobenzoates/chemistry ; Aminobenzoates/therapeutic use ; Aminoglycosides/therapeutic use ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/chemistry ; Clinical Trials as Topic ; Drug Delivery Systems ; Drug Design ; Gemtuzumab ; Humans ; Immunoconjugates/chemistry ; Immunotoxins/chemistry ; Immunotoxins/therapeutic use ; Maytansine/administration & dosage ; Maytansine/chemistry ; Maytansine/therapeutic use ; Oligopeptides/administration & dosage ; Oligopeptides/chemistry ; Oligopeptides/therapeutic use ; Structure-Activity Relationship
-
8دورية أكاديمية
عنوان ترانسليتريتد: Anticorps et tumeurs solides : cibles établies et pistes prometteuses.
المؤلفون: Bodmer A; Hôpitaux universitaires de Genève, Centre d'oncologie, rue Gabrielle Perret Gentil, 1211 Genève 14, France., Goetsch L, Favet L, Bailly C, Corvaia N, Dietrich PY
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1090-8.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents/*therapeutic use , Neoplasm Proteins/*antagonists & inhibitors , Neoplasms/*drug therapy, Antibodies, Monoclonal, Humanized ; Cetuximab ; Clinical Trials as Topic ; Drug Delivery Systems ; Drug Design ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/immunology ; ErbB Receptors/physiology ; Humans ; Multigene Family ; Neoplasm Proteins/immunology ; Neoplasm Proteins/physiology ; Neoplasms/immunology ; Patient Selection ; Proto-Oncogene Proteins c-met/antagonists & inhibitors ; Proto-Oncogene Proteins c-met/immunology ; Proto-Oncogene Proteins c-met/physiology ; Receptor, ErbB-2/antagonists & inhibitors ; Receptor, ErbB-2/immunology ; Receptor, ErbB-2/physiology ; Receptor, IGF Type 1/antagonists & inhibitors ; Receptor, IGF Type 1/immunology ; Receptor, IGF Type 1/physiology ; Trastuzumab
-
9دورية أكاديمية
عنوان ترانسليتريتد: Les anticorps radiomarqués pour le traitement des cancers.
المؤلفون: Barbet J; Centre de recherche en cancérologie de Nantes-Angers, Université de Nantes, Inserm, U892, Institut de biologie, 9, quai Moncousu, 44000 Nantes, France. Jacques.Barbet@nantes.inserm.fr, Chatal JF, Kraeber-Bodéré F
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1039-45.
نوع المنشور: English Abstract; Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Radioimmunotherapy*, Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents/*therapeutic use , Immunoconjugates/*therapeutic use , Neoplasms/*radiotherapy, Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/chemistry ; Antineoplastic Agents/pharmacokinetics ; Biotinylation ; Combined Modality Therapy ; Drug Administration Schedule ; Drug Delivery Systems ; Haptens/administration & dosage ; Hematologic Neoplasms/radiotherapy ; Humans ; Immunoconjugates/pharmacokinetics ; Immunoglobulin G/chemistry ; Immunoglobulin G/therapeutic use ; Models, Molecular ; Myeloablative Agonists/therapeutic use ; Neoplasms/pathology ; Neoplasms/therapy ; Protein Conformation ; Radioimmunodetection ; Tissue Distribution
-
10دورية أكاديمية
عنوان ترانسليتريتد: Anti-VEGF : applications pratiques en ophtalmologie.
المؤلفون: Leveziel N; Service d'ophtalmologie (Pr Eric Souied), Hôpital intercommunal de Créteil, 40, avenue de Verdun, 94000 Créteil, France. nicolas.leveziel@yahoo.fr, Soubrane G, Souied EH
المصدر: Medecine sciences : M/S [Med Sci (Paris)] 2009 Dec; Vol. 25 (12), pp. 1105-7.
نوع المنشور: English Abstract; Journal Article; Review
بيانات الدورية: Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print Cited Medium: Print ISSN: 0767-0974 (Print) Linking ISSN: 07670974 NLM ISO Abbreviation: Med Sci (Paris) Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Macular Degeneration/*drug therapy , Vascular Endothelial Growth Factor A/*antagonists & inhibitors, Aged ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Choroidal Neovascularization/drug therapy ; Choroidal Neovascularization/physiopathology ; Drug Delivery Systems ; Humans ; Macular Degeneration/physiopathology ; Middle Aged ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Ranibizumab ; Retinal Neovascularization/drug therapy ; Retinal Neovascularization/physiopathology ; Vascular Endothelial Growth Factor A/immunology